Literature DB >> 574813

Dietary cyanide and tropical malnutrition diabetes.

D E McMillan, P J Geevarghese.   

Abstract

Two categories of diabetes are recognized in the temperate zone--ketosis-prone diabetes requiring insulin and diabetes not requiring insulin. Another unique type of diabetes occurs in the tropics. It has two forms, both different from either form of temperate zone diabetes. Type J and pancreatic diabetes are both characterized by youth onset, antecedent malnutrition, substantial insulin requirement, and resistance to ketosis. In the tropical countries where they are found, both forms are associated with specific dietary practices, including a nutritionally marginal protein intake. The close association with low protein intake distinguishes this form of diabetes from that occurring in North America, Europe, and Oceania. The geographic distribution of malnutrition diabetes, in addition to being limited to the tropics, coincides regularly with the consumption of tapioca (cassava) or other foods that contain cyanide-yielding substances. Ingested cyanide is normally detoxified, principally, by conversion to thiocyanate. This detoxification requires sulfur, derived principally from amino acid sources. Studies in the rat indicate a remarkable ability to detoxify ingested cyanide, a reduction in urinary thiocyanate excretion when protein intake is lowered (especially during growth), production of marked hyperglycemia by either oral or parenteral cyanide, and the development of cyanosis and epidermal changes when there is prolonged exposure to cyanide. Both the association of malnutrition diabetes with food cyanogens and our laboratory observations support a role for cyanide in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 574813     DOI: 10.2337/diacare.2.2.202

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  29 in total

Review 1.  Relation between malnutrition and development of diabetes mellitus.

Authors:  A N al-Amin; B Ahrén
Journal:  Int J Pancreatol       Date:  1999-12

2.  J type diabetes revisited.

Authors:  E Y Morrison; D Ragoobirsingh
Journal:  J Natl Med Assoc       Date:  1992-07       Impact factor: 1.798

3.  Association of hyperglycemia with dietary cyanogen and socio-economic level. The study of rural communities in south-east Nigeria.

Authors:  J O Akpan; R L Gingerich
Journal:  Acta Diabetol Lat       Date:  1991 Jan-Mar

Review 4.  Genetic mechanisms underlying the pathogenesis of tropical calcific pancreatitis.

Authors:  Swapna Mahurkar; D Nageshwar Reddy; G Venkat Rao; Giriraj Ratan Chandak
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

5.  Improving the management of dysglycemia in children in the developing world.

Authors:  Hubert Barennes; Eric Pussard
Journal:  Am J Trop Med Hyg       Date:  2014-10-13       Impact factor: 2.345

Review 6.  Type 2 (non-insulin-dependent) diabetes--an epidemiological overview.

Authors:  P Zimmet
Journal:  Diabetologia       Date:  1982-06       Impact factor: 10.122

7.  Tropical pancreatic diabetes in South India: heterogeneity in clinical and biochemical profile.

Authors:  V Mohan; R Mohan; L Susheela; C Snehalatha; G Bharani; V K Mahajan; A Ramachandran; M Viswanathan; E M Kohner
Journal:  Diabetologia       Date:  1985-04       Impact factor: 10.122

Review 8.  Tropical chronic pancreatitis.

Authors:  K K Barman; G Premalatha; V Mohan
Journal:  Postgrad Med J       Date:  2003-11       Impact factor: 2.401

Review 9.  Diabetes in the tropics: differences from diabetes in the West.

Authors:  V Mohan; J M Ekoe; A Ramachandran; C Snehalatha; M Viswanathan
Journal:  Acta Diabetol Lat       Date:  1986 Apr-Jun

10.  Mantakassa: an epidemic of spastic paraparesis associated with chronic cyanide intoxication in a cassava staple area of Mozambique. 2. Nutritional factors and hydrocyanic acid content of cassava products. Ministry of Health, Mozambique.

Authors: 
Journal:  Bull World Health Organ       Date:  1984       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.